IWA
ICPT

Intercontinental Wealth Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Intercontinental Wealth Advisors’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-336
Closed -$34K – 459
2018
Q4 		$34K Buy
+336
New +$34.8K 0.02% 255

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Intercontinental Wealth Advisors's ICPT Position: Q1 2019 in Review

Intercontinental Wealth Advisors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2019, closing a stake of 336 shares — an estimated $34K sold.

Intercontinental Wealth Advisors first reported a position in ICPT in Q4 2018 and held it in 1 quarter. The position peaked at $34K in Q4 2018. 202 funds tracked by Wall St. Rank hold ICPT as of Q1 2019.

  • Intercontinental Wealth Advisors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
  • Intercontinental Wealth Advisors sold 336 Intercept Pharmaceuticals, Inc. shares in Q1 2019, an estimated $34K.
  • Intercontinental Wealth Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2018 and held it in 1 quarter.
  • Intercontinental Wealth Advisors's Intercept Pharmaceuticals, Inc. position peaked at $34K in Q4 2018.
  • 202 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2019.

Based on Intercontinental Wealth Advisors's 13F filing for Q1 2019, filed 8 May 2019.